Kepos Capital LP Ardelyx, Inc. Transaction History
Kepos Capital LP
- $121 Million
- Q1 2025
Shares
2 transactions
Others Institutions Holding ARDX
# of Institutions
236Shares Held
166MCall Options Held
490KPut Options Held
2.35M-
Janus Henderson Group PLC London, X025MShares$97.9 Million0.07% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$68.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15MShares$58.8 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C311.2MShares$43.7 Million0.07% of portfolio
-
State Street Corp Boston, MA10.2MShares$39.9 Million0.0% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $606M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...